Company profile
UK company 12850396, incorporated on 1 September 2020.
Orbit Discovery Delivering Peptide Enabled Drug Discovery Solutions
Orbit Discovery Ltd is a UK company with status In Administration founded in 2020 based in South East England.
Company number 12850396
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
AM03 | Transaction MzU0Mzg4NzA1OGFkaXF6a2N4 | Paper/PDF filed
Published 21 Sep 2026 22:52
Next confirmation statement due date
AD01 | Transaction MzUzNzM5NzU4NWFkaXF6a2N4 | Paper/PDF filed
Published 20 Aug 2026 23:26
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
Peptide drug discovery company
None yet
1 Apr 2024 to 31 Mar 2026
ProteinQure and Orbit Discovery are developing a new peptide discovery platform that can be commercialized as well as specific therapeutic molecules addressing key unmet needs. In particular we aim to develop novel peptide ligands using ProteinQure's Artificial Intelligence (AI) Platform to design custom libraries which will be subsequently utilised in fu...
1 Jun 2022 to 30 Nov 2023
Orbit Discovery is a UK-based SME pioneering the discovery and development of novel peptide therapeutics. Peptides represent a unique class of pharmaceutical compound, having incredibly high chemical diversity, molecularly poised between small molecules and proteins, yet biochemically and therapeutically distinct from both. Peptide therapeutics typically ...
